1. Home
  2. AGIO vs IMKTA Comparison

AGIO vs IMKTA Comparison

Compare AGIO & IMKTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Agios Pharmaceuticals Inc.

AGIO

Agios Pharmaceuticals Inc.

HOLD

Current Price

$34.45

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Logo Ingles Markets Incorporated

IMKTA

Ingles Markets Incorporated

HOLD

Current Price

$90.19

Market Cap

1.6B

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGIO
IMKTA
Founded
2007
1963
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Food Chains
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.6B
IPO Year
2013
1994

Fundamental Metrics

Financial Performance
Metric
AGIO
IMKTA
Price
$34.45
$90.19
Analyst Decision
Buy
Analyst Count
8
0
Target Price
$39.88
N/A
AVG Volume (30 Days)
969.5K
105.6K
Earning Date
04-29-2026
05-07-2026
Dividend Yield
N/A
0.73%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$43,011,000.00
$5,334,032,609.00
Revenue This Year
$74.95
N/A
Revenue Next Year
$165.77
N/A
P/E Ratio
N/A
$15.91
Revenue Growth
N/A
N/A
52 Week Low
$22.24
$59.09
52 Week High
$46.00
$95.62

Technical Indicators

Market Signals
Indicator
AGIO
IMKTA
Relative Strength Index (RSI) 66.34 54.50
Support Level $26.64 $68.14
Resistance Level $36.35 N/A
Average True Range (ATR) 1.38 2.21
MACD 0.08 -0.13
Stochastic Oscillator 71.17 56.10

Price Performance

Historical Comparison
AGIO
IMKTA

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236 and others.

About IMKTA Ingles Markets Incorporated

Ingles Markets Inc is a U.S.-based company that is principally engaged in operating a supermarket chain. The company operates the business in the southeast United States, mainly in Georgia, North Carolina, South Carolina, and Tennessee, with a few stores in Virginia and Alabama as well. The company locates its stores majorly in suburban areas, small towns, and neighborhood areas. It offers a broad range of goods, including food products, pharmacies, health and beauty care products, and general merchandise. The retail business contributes the majority of the company's revenue. The company's real estate ownership of a material portion of total stores enables it to generate rental income.

Share on Social Networks: